A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
This Phase 1 study is designed to determine the photoirritation potential of PEP005 Gel, 0.01% when application is followed by light exposure.
Actinic Keratosis
DRUG: PEP005 (ingenol mebutate) Gel
To determine the photoirritation potential of PEP005 Gel, when application is followed by light exposure., 4 days
This Phase 1 study is designed to determine the photoirritation potential of PEP005 Gel, 0.01% when application is followed by light exposure.